Advertisement
Corcept Therapeutics Incorporated (CORT)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 55.92 |
| Open | 56.20 |
| Bid | 57.40 x 100 |
| Ask | 57.71 x 100 |
| Day's Range | 56.15 - 57.71 |
| 52 Week Range | 20.84 - 61.66 |
| Volume | |
| Avg. Volume | 962,929 |
| Market Cap | 6.029B |
| Beta (5Y Monthly) | 0.46 |
| PE Ratio (TTM) | 45.67 |
| EPS (TTM) | 1.26 |
| Earnings Date | Feb 13, 2025 - Feb 17, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 74.90 |
ZacksCorcept Shares Rise More Than 60% in Three Months: Here's Why
CORT's Cushing's syndrome drug, Korlym, is driving revenues. The NDA for relacorilant in Cushing's syndrome will be filed shortly.
Zacks3 Reasons Growth Investors Will Love Corcept (CORT)
Corcept (CORT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.